A federal district judge on Friday held “pharma bro” Martin Shkreli liable for antitrust claims brought by the Federal Trade Commission (FTC) and seven states.
U.S. Senior District Judge Denise Cote of the Southern District of New York imposed a lifetime ban against Shkreli participating in the pharmaceutical industry and ordered him to pay $64.6 million to offset ill-gotten gains. Shkreli’s former company and former business partner agreed last month to settle anticompetitive conduct claims against them.
A federal district judge on Friday held “pharma bro” Martin Shkreli liable for antitrust claims brought by the Federal Trade Commission (FTC) and seven states.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
